PMID: 16507219Mar 2, 2006Paper

Phenoxodiol: isoflavone analog with antineoplastic activity

Current Oncology Reports
T K ChoueiriT Mekhail

Abstract

Phenoxodiol, a synthetic analog of the plant isoflavone genistein, represents a new generation of oncology drugs acting as multiple signal transduction regulators. Phenoxodiol exerts its effect mainly by the induction of apoptosis through multiple mechanisms resulting in degradation of antiapoptotic proteins, with increased levels being linked to chemoresistance in tumor cells. Preclinical studies with this agent showed promising anticancer activity leading to a potential role in the treatment of a wide range of solid and hematologic cancers. Early clinical studies, especially in chemotherapy-resistant ovarian cancer, showed minimal toxicity with minor antitumor activity. Hormone-refractory prostate cancer is another promising area in which phenoxodiol is being actively tested. Studies are ongoing to define the optimal use of this novel anticancer agent.

References

Apr 1, 1992·European Journal of Clinical Investigation·L SchweigererT Fotsis
Jan 1, 1995·Proceedings of the Society for Experimental Biology and Medicine·A Constantinou, E Huberman
Apr 1, 1997·Annals of Medicine·H Adlercreutz, W Mazur
Mar 10, 1998·Proceedings of the Society for Experimental Biology and Medicine·C A LamartiniereN M Brown
Oct 21, 2000·Experimental Eye Research·A M JoussenF E Kruse
Apr 3, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G K SchwartzD Kelsen
Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary K SchwartzDavid Kelsen
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G FreyerV Trillet-Lenoir
Apr 23, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A I ConstantinouA Husband
May 9, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C Tom KouroukisUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Dec 11, 2003·Molecular Human Reproduction·Shawn L Straszewski-ChavezGil Mor
Jan 1, 2004·The Lancet Oncology·Charles Swanton
May 29, 2004·Anti-cancer Drugs·Elizabeth W Newcomb
Dec 9, 2004·Advances in Experimental Medicine and Biology·Mepur H RavindranathSubramanian Viswanathan
Jun 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John C ByrdUNKNOWN Cancer and Leukemia Group B
Sep 29, 2005·JAMA : the Journal of the American Medical Association·Matthew B SchabathMargaret R Spitz

❮ Previous
Next ❯

Citations

Jan 19, 2016·Biochemical Pharmacology·Urszula LewandowskaSylwia Gorlach
Mar 17, 2010·Phytochemistry Letters·Li PanA Douglas Kinghorn
Jun 17, 2008·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Marianne ImhofMartin Imhof
Apr 15, 2017·Bioorganic & Medicinal Chemistry Letters·Eugene M H YeeNaresh Kumar
Aug 29, 2007·Acta Pharmacologica Sinica·Fazlul H Sarkar, Yi-wei Li
Feb 12, 2009·British Journal of Cancer·R A C McPhersonP L de Souza
Aug 4, 2012·Biomedit︠s︡inskai︠a︡ khimii︠a︡·V N Zinov'eva, A A Spasov
Jul 8, 2019·Naunyn-Schmiedeberg's Archives of Pharmacology·Madeline FinkFlorian Lang
Aug 24, 2019·Frontiers in Bioengineering and Biotechnology·Eugene M H YeeNaresh Kumar
Apr 17, 2020·Current Topics in Medicinal Chemistry·Esra Küpeli AkkolHaroon Khan
Jul 27, 2021·Current Therapeutic Research, Clinical and Experimental·Koba KiknavelidzeGraham Kelly

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.